Alzheimer's drug trial halted early – what did we learn?
Disease control
Terminated
This study tested an experimental drug called varoglutamstat (PQ912) in people with early Alzheimer's disease. The goal was to see if it was safe and could slow down memory and thinking problems. The trial was stopped early, but researchers looked at how the drug affected brain a…
Phase: PHASE2 • Sponsor: Vivoryon Therapeutics N.V. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC